JP2007246474A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007246474A5 JP2007246474A5 JP2006074822A JP2006074822A JP2007246474A5 JP 2007246474 A5 JP2007246474 A5 JP 2007246474A5 JP 2006074822 A JP2006074822 A JP 2006074822A JP 2006074822 A JP2006074822 A JP 2006074822A JP 2007246474 A5 JP2007246474 A5 JP 2007246474A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrogen atom
- alkyl
- aryl
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (2)
R1及びR2は同一又は異なって、水素原子、アルキル基、アリール基、ヘテロアリール基、ハロゲン原子、ハロアルキル基、アルキルオキシ基、ハロアルキルオキシ基、シアノ基、ニトロ基を;
R3及びR4は同一又は異なって、水素原子又はアルキル基を示し、又はR3及びR4は互いに結合してシクロアルキル基を形成し;
R5は水素原子又はアルキル基を;
R6は水素原子又はアルキル基を;
R7はアルキル基、ハロアルキル基又はアリール基を;
Qは酸素原子又は硫黄原子を示す。なお、前記基のうち、アルキル基、アリール基は、それぞれ置換基を有していてもよい。}を示し;
nは1〜5の整数を;
Yは酸素原子、硫黄原子、−NR8−、−CONR8−、−NR8CO−又はNHCONR8−(式中、R8は水素原子、アルキル基、アリール基、ヘテロアリール基、シクロアルキルアルキル基、アリールアルキル基、アリールアルケニル基、アリールオキシアルキル基又はヘテロアリールアルキル基を示す。)を;
Zはアリール基、ヘテロアリール基、アリールアルキル基、ヘテロアリールアルキル基又はシクロアルキル基を示す。
なお、前記基のうち、アルキル基、アリール基、ヘテロアリール基、シクロアルキルアルキル基、アリールアルキル基、アリールアルケニル基、アリールオキシアルキル基又はヘテロアリールアルキル基は、それぞれ置換基を有していてもよい。〕で表されるベンゼン誘導体若しくはその薬剤上許容される塩又はそれらの水和物若しくは溶媒和物。 The following general formula (I)
R 1 and R 2 are the same or different and each represents a hydrogen atom, an alkyl group, an aryl group, a heteroaryl group, a halogen atom, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, a cyano group, or a nitro group;
R 3 and R 4 are the same or different and represent a hydrogen atom or an alkyl group, or R 3 and R 4 are bonded to each other to form a cycloalkyl group;
R 5 represents a hydrogen atom or an alkyl group;
R 6 represents a hydrogen atom or an alkyl group;
R 7 represents an alkyl group, a haloalkyl group or an aryl group;
Q represents an oxygen atom or a sulfur atom. Of the above groups, the alkyl group and the aryl group each may have a substituent. }
n is an integer from 1 to 5;
Y is an oxygen atom, a sulfur atom, —NR 8 —, —CONR 8 —, —NR 8 CO— or NHCONR 8 — (wherein R 8 is a hydrogen atom, an alkyl group, an aryl group, a heteroaryl group, a cycloalkylalkyl. A group, an arylalkyl group, an arylalkenyl group, an aryloxyalkyl group or a heteroarylalkyl group);
Z represents an aryl group, heteroaryl group, arylalkyl group, heteroarylalkyl group or cycloalkyl group.
Of the above groups, the alkyl group, aryl group, heteroaryl group, cycloalkylalkyl group, arylalkyl group, arylalkenyl group, aryloxyalkyl group or heteroarylalkyl group may each have a substituent. Good. Or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006074822A JP5243696B2 (en) | 2006-03-17 | 2006-03-17 | Benzene derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006074822A JP5243696B2 (en) | 2006-03-17 | 2006-03-17 | Benzene derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007246474A JP2007246474A (en) | 2007-09-27 |
JP2007246474A5 true JP2007246474A5 (en) | 2009-01-22 |
JP5243696B2 JP5243696B2 (en) | 2013-07-24 |
Family
ID=38591139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006074822A Expired - Fee Related JP5243696B2 (en) | 2006-03-17 | 2006-03-17 | Benzene derivatives |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5243696B2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007287428B2 (en) | 2006-08-24 | 2011-08-11 | Astrazeneca Ab | Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
FR2917086B1 (en) * | 2007-06-05 | 2009-07-17 | Galderma Res & Dev | NOVEL 3-PHENYL ACRYLIC ACIDIC ACID DERIVATIVES OF PPAR TYPE RECEPTORS, THEIR METHOD OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS. |
FR2917084B1 (en) * | 2007-06-05 | 2009-07-17 | Galderma Res & Dev | NOVEL 3-PHENYL PROPANOIC ACID DERIVATIVES OF PPAR-TYPE RECEPTORS, THEIR METHOD OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS |
JP5508260B2 (en) | 2007-07-09 | 2014-05-28 | アストラゼネカ アクチボラグ | Morpholinopyrimidine derivatives used for diseases related to mTOR kinase and / or P13K |
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
US20090270398A1 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Pyridazine Derivatives |
WO2009131957A2 (en) | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising oxadiazole derivatives |
WO2009131951A2 (en) | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
US8343976B2 (en) | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
WO2011107494A1 (en) | 2010-03-03 | 2011-09-09 | Sanofi | Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof |
EP2560488B1 (en) | 2010-04-23 | 2015-10-28 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
AR081331A1 (en) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME |
AR081626A1 (en) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS |
SA111320519B1 (en) | 2010-06-11 | 2014-07-02 | Astrazeneca Ab | Pyrimidinyl Compounds for Use as ATR Inhibitors |
WO2011157827A1 (en) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2012120052A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120054A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683699B1 (en) | 2011-03-08 | 2015-06-24 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013122028A1 (en) * | 2012-02-13 | 2013-08-22 | 武田薬品工業株式会社 | Aromatic ring compound |
JPWO2015163435A1 (en) * | 2014-04-24 | 2017-04-20 | 田辺三菱製薬株式会社 | Novel 2-amino-pyridine and 2-amino-pyrimidine derivatives and their pharmaceutical use |
CN115477588B (en) * | 2022-09-30 | 2023-11-17 | 中国药科大学 | Lipid regulating compound based on cholesterol reverse transport path, synthesis method and application |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
JP4383177B2 (en) * | 2002-03-01 | 2009-12-16 | スミスクライン ビーチャム コーポレーション | hPPAR activator |
US6653334B1 (en) * | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
-
2006
- 2006-03-17 JP JP2006074822A patent/JP5243696B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007246474A5 (en) | ||
JP2007508359A5 (en) | ||
JP2017519781A5 (en) | ||
JP2019529490A5 (en) | ||
JP2009263394A5 (en) | ||
JP2010501478A5 (en) | ||
JP2005519932A5 (en) | ||
JP2008505157A5 (en) | ||
JP2012533546A5 (en) | ||
JP2017524025A5 (en) | ||
JP2005539088A5 (en) | ||
JP2005053931A5 (en) | ||
JP2003519676A5 (en) | ||
JP2007508362A5 (en) | ||
JP2007538031A5 (en) | ||
JP2010535722A5 (en) | ||
JP2009530306A5 (en) | ||
JP2009502770A5 (en) | ||
RU2007108863A (en) | Pyrazole derivatives for the treatment of conditions mediated by activation of an adenosine A2B or A3 receptor | |
JP2007520440A5 (en) | ||
JP2010504908A5 (en) | ||
JP2005289914A5 (en) | ||
JP2005527542A5 (en) | ||
JP2007517826A5 (en) | ||
JP2003534359A5 (en) |